These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4607702)

  • 21. The effect of lipids on prolactin and growth hormone secretion.
    Fraser WM; Blackard WG
    Horm Metab Res; 1977 Sep; 9(5):389-94. PubMed ID: 411724
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of adrenaline on insulin-induced release of growth hormone and cortisol in man.
    Müller-Hess R; Geser CA; Jéquier E; Felber JP; Vannotti A
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):260-73. PubMed ID: 4406545
    [No Abstract]   [Full Text] [Related]  

  • 23. Close juxtapositions between luteinizing hormone-releasing hormone-immunoreactive neurons and corticotropin-releasing factor-immunoreactive axons in the human diencephalon.
    Dudás B; Merchenthaler I
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5778-84. PubMed ID: 12466386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind controlled study of pimozide vs chlorpromazine in mania.
    Cookson JC; Silverstone T; Wells B
    Neuropharmacology; 1979 Dec; 18(12):1011-3. PubMed ID: 394017
    [No Abstract]   [Full Text] [Related]  

  • 25. New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man.
    Grossman A; Kruseman AC; Perry L; Tomlin S; Schally AV; Coy DH; Rees LH; Comaru-Schally AM; Besser GM
    Lancet; 1982 Apr; 1(8278):921-2. PubMed ID: 6122767
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies in congenital generalized lipodystrophy. 3. Growth hormone levels.
    Oseid S
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):427-36. PubMed ID: 4740840
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of chlorpromazine on serum growth-hormone concentration in man.
    Sherman L; Kim S; Benjamin F; Kolodny HD
    N Engl J Med; 1971 Jan; 284(2):72-4. PubMed ID: 5538637
    [No Abstract]   [Full Text] [Related]  

  • 28. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
    Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of apomorphine combined with chlorpromazine and pimozide on the estrous cycle in rats.
    Kun I; Cuparencu B; Feszt G; Orbán I
    Endokrinologie; 1977 Oct; 70(2):124-30. PubMed ID: 563325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoatrophic diabetes: a new variant characterized by tapeto-retinal degeneration, late onset generalized lipoatrophy, insulin-resistant hyperglycemia and hyperlipidemia.
    Wajchenberg BL; Modesto Filho J; Ventrella C; Giannini SD; Liberman B; Hoxter G
    Isr J Med Sci; 1972 Jun; 8(6):793-806. PubMed ID: 5051798
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the quality of hormones in blood plasma and ischemic heart disease risk factors in 40--59-year-old men].
    Gerasimova EN; Glazunov IS; Bodrova EA; Suchkova SN; Zykova VP
    Vopr Med Khim; 1978; 24(5):657-66. PubMed ID: 212869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK; Losa M; Oeckler R; Müller OA; von Werder K
    Horm Res; 1988; 29(5-6):191-6. PubMed ID: 2851521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholine stimulates the secretion of corticotropin-releasing factor from primary dissociated cell cultures of the rat telencephalon and diencephalon.
    Hillhouse E; Reichlin S
    Brain Res; 1990 Jan; 506(1):9-13. PubMed ID: 2302559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory role of dopamine and 5-hydroxytryptamine in the sexual behaviour of female rats.
    Everitt BJ; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1974 Nov; 29(1):187-91. PubMed ID: 4279825
    [No Abstract]   [Full Text] [Related]  

  • 36. Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
    Choudhury SA; Sharpe RM; Brown PS
    Neuroendocrinology; 1973; 12(4):272-83. PubMed ID: 4731030
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind controlled study of pimozide versus chlorpromazine in mania.
    Cookson JC; Silverstone T; Wells B
    Psychopharmacol Bull; 1980 Jul; 16(3):38-41. PubMed ID: 7403398
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined test for assessment of anterior pituitary function.
    Harsoulis P; Marshall JC; Kuku SF; Burke CW; London DR; Fraser TR
    Br Med J; 1973 Nov; 4(5888):326-9. PubMed ID: 4202260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies.
    Sorem KA; Smikle CB; Spencer DK; Yoder BA; Graveson MA; Siler-Khodr TM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):912-6. PubMed ID: 8885747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine derangement in chronic migraine.
    Patacchioli FR; Martelletti P
    Headache; 2006 Sep; 46(8):1309-10. PubMed ID: 16942481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.